Back to Search
Start Over
RADIOTHERAPY BRIDGING IN LARGE B‐CELL LYMPHOMA PATIENTS RECEIVING CD19 CAR‐T – THE UK EXPERIENCE.
- Source :
- Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p217-218, 2p
- Publication Year :
- 2023
-
Abstract
- High-precision, individualised RT protocols allowed successful tumour de-bulking with limited toxicity, providing the basis to develop specific RT bridging protocols in lymphoma. RADIOTHERAPY BRIDGING IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CD19 CAR-T - THE UK EXPERIENCE B Background: b Radiotherapy (RT) has potential synergistic effects with CAR T but is not widely used as bridging therapy for lymphoma patients due to logistical challenges, uncertainty about patient selection and lack of standardised protocols. [Extracted from the article]
- Subjects :
- CD19 antigen
LYMPHOMAS
COMBINED modality therapy
Subjects
Details
- Language :
- English
- ISSN :
- 02780232
- Volume :
- 41
- Database :
- Complementary Index
- Journal :
- Hematological Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 164230927
- Full Text :
- https://doi.org/10.1002/hon.3163_141